What is the RBANS? Pearson's brief neuropsychological battery explained

The RBANS, short for the Repeatable Battery for the Assessment of Neuropsychological Status, is a brief neuropsychological test battery published by Pearson and authored by neuropsychologist Christopher Randolph. It takes about 30 minutes to administer, covers five cognitive domains (immediate memory, visuospatial and constructional skills, language, attention, and delayed memory), and produces a total score on the familiar mean-100 scale. Its defining feature is right there in the name: it was built to be repeatable, with four parallel forms so clinicians can retest the same person without the questions being memorized. This article explains what the RBANS measures, how it is scored, who takes it, and how a brief battery like this differs from a full neuropsychological evaluation or an IQ test.

The original RBANS appeared in 1998. In the journal article introducing it, Randolph and colleagues explained that the battery was developed for two purposes: identifying and characterizing abnormal cognitive decline in older adults, and serving as a quick neuropsychological screening tool for younger patients. The same article reported that the whole battery takes less than 30 minutes and yields scores for five cognitive domains.

The current version is the RBANS Update, which Pearson lists with a 2012 publication date. According to the publisher, the Update kept the structure of the original while extending the age range downward to 12 years, adding subtest scores alongside the index scores, and refreshing the manual with new research, including information on adolescents. Pearson describes the RBANS Update as "a brief, individually administered battery to measure cognitive decline or improvement" for people aged 12 years 0 months through 89 years 11 months.

A trained examiner gives the test one-on-one, using a spiral-bound stimulus booklet, either on paper or through Pearson's digital Q-interactive platform. Pearson classifies it at qualification level B, which generally means purchasers need relevant graduate training or certification in assessment. Spanish-language forms are also available.

The RBANS contains 12 short subtests that combine into five "index scores," which are standard scores summarizing performance in each cognitive domain. According to Pearson, the five domains are immediate memory, visuospatial/constructional ability, language, attention, and delayed memory. In the research literature, the subtests are grouped this way:

• Immediate memory: List Learning (recalling a word list read aloud over several trials) and Story Memory (retelling a short story). This index captures how well a person takes in new verbal information right after hearing it.

• Visuospatial/constructional: Figure Copy (drawing a complex geometric figure) and Line Orientation (judging the angles of lines). These tasks measure spatial perception and the ability to reproduce what one sees.

• Language: Picture Naming (naming pictured objects) and Semantic Fluency (listing as many items from a category as possible in a set time).

• Attention: Digit Span (repeating strings of digits) and Coding (rapidly matching symbols to numbers using a key). These tasks tap concentration and speed of mental processing.

• Delayed memory: List Recall, List Recognition, Story Recall, and Figure Recall, all of which ask the examinee to remember material from earlier subtests after a delay. Delayed memory is weighted heavily because memory loss after a delay is a hallmark of many dementias. For a broader look at how examiners measure remembering, see our guide to how memory tests work.

Each index is reported as a standard score, and the battery also yields a total scale score. In an early validation study, Gold and colleagues described the test as providing a total score and five index scores, each with a mean of 100 and a "standard deviation" (a measure of how spread out scores are) of 15 points, normed on a sample matched to the United States census. That is the same metric used by major IQ tests, so a score of 100 sits at the average of the norm group. Published clinical trials that use the RBANS report the total score range as 40 to 160, with the total derived from the 12 subtest scores and adjusted for age.

Most cognitive tests have a weakness: give the same test twice and the second score benefits from a "practice effect," meaning improvement that comes from familiarity with the items rather than genuine cognitive change. The RBANS was designed around this problem. According to Pearson, the RBANS Update offers four parallel forms. Form A carries the full normative sample, with norms based on age, gender, race, education, and geographic region, and equating studies adjust Forms B through D (and the Spanish Form A) so their scores line up with Form A.

This matters because the RBANS is often used to track change over time. Pearson lists repeat evaluation as a core use case: measuring recovery during rehabilitation, following the progression of a neurological disorder, or serving as a repeated outcome measure in clinical trials, where researchers need to test the same patients every few months without the content growing stale. Alternating forms lets a clinician retest sooner and with less worry that the second score is inflated by memory for specific items.

The RBANS was originally developed with a primary focus on dementia assessment, and Pearson still describes its use as a stand-alone "core" battery for detecting and characterizing dementia in older adults. The publisher reports special group studies for Alzheimer's disease, vascular dementia, HIV dementia, Huntington's disease, Parkinson's disease, depression, schizophrenia, and closed head injury, along with screening uses in acute care settings and with adolescents.

The peer-reviewed literature backs up this range. In the original 1998 validity study, patients with Alzheimer's disease and patients with Huntington's disease earned nearly identical total scores but showed opposite profiles across the five indexes, which is exactly what a battery meant to characterize different dementias should show. Wilde examined 210 patients on an inpatient rehabilitation unit after acute ischemic stroke and found that left- and right-hemisphere stroke patients showed the expected differences on verbal versus visuospatial factors. McKay and colleagues compared 51 people with traumatic brain injury to controls and reported that the TBI group scored significantly lower across the index scores, with the total score doing particularly efficient work in separating the groups.

Schizophrenia research adopted the RBANS early. Gold and colleagues gave it to 129 patients with schizophrenia and found marked impairment (a mean total score of 71.4), strong correlations with full-length IQ and memory tests, and a meaningful relationship between RBANS scores and whether patients were employed. A companion study replicated the pattern in a broader psychiatric sample. Because cognitive impairment is a core feature of schizophrenia, a reliable 30-minute battery gave researchers a practical way to measure it at scale.

It is worth distinguishing the RBANS from even shorter cognitive screeners. Tools like the MoCA take about 10 minutes and produce a single rough score. The RBANS sits a level up: still brief, but normed like a full psychological test and detailed enough to show a profile across domains.

A brief battery like the RBANS samples the major cognitive domains quickly, which makes it useful when a lengthy assessment is impractical, such as at a hospital bedside or in a clinical trial visit. Pearson itself positions the RBANS as a "screen battery" for situations where lengthier standardized assessments are impractical or inappropriate. A full neuropsychological evaluation goes much deeper: a neuropsychologist selects a longer set of tests, integrates medical history, interviews, and behavioral observation, and writes a diagnostic report. The RBANS can flag that something is wrong and sketch the shape of the problem; the full evaluation explains it.

An IQ test answers a different question altogether. Rather than hunting for impairment, an intelligence test estimates a person's general reasoning ability relative to the population. The two overlap statistically (Gold and colleagues found high correlations between RBANS totals and full-scale IQ), but the RBANS is built to detect decline and change in clinical populations, and it deliberately trades breadth of reasoning content for speed and repeatability.

For a healthy adult who simply wants to know where their cognitive abilities stand, a clinical screening battery is the wrong tool, and an online reasoning test with proper norms is a reasonable one. The RIOT IQ test (the Reasoning and Intelligence Online Test), developed by RIOT IQ with psychometrician Dr. Russell T. Warne, measures adults aged 18 and older with 15 subtests across six cognitive indices (verbal reasoning, fluid reasoning, spatial ability, working memory, processing speed, and reaction time). It takes about 52 minutes and reports scores on the same mean-100, standard-deviation-15 scale described above. It is a measurement tool for healthy adults, and it does not replace an individually administered diagnostic evaluation such as a neuropsychological workup. If you want a careful estimate of your reasoning ability from a properly normed instrument, you can take the RIOT IQ test.

Pearson lists the completion time as 30 minutes. Early studies reported administration times of roughly 25 to 30 minutes, which is why it is classed as a brief battery.

The RBANS Update covers ages 12 years 0 months through 89 years 11 months, according to Pearson. The original version was an adult battery; the Update extended the range down to age 12.

The total score and the five index scores each have a mean of 100 and a standard deviation of 15 in the norm sample, so about two thirds of people score between 85 and 115. Reported total scores range from 40 to 160.

No. RBANS scores correlate substantially with IQ scores, but the battery is designed to detect and track cognitive impairment, and its content emphasizes memory and quick screening rather than the breadth of reasoning tasks an intelligence test uses.

To control practice effects. Parallel forms A through D contain different items that are statistically equated, so a clinician can retest a patient and read the change as real rather than as familiarity with the questions.

Pearson sells it at qualification level B, which generally requires graduate-level training in psychological assessment. It is given one-on-one by a trained examiner, on paper or digitally.

1. Pearson. (n.d.). Repeatable Battery for the Assessment of Neuropsychological Status Update (RBANS Update). Pearson Assessments. pearsonassessments.com

2. Pearson. (2020). Table 2. RBANS subtest input and output requirements and equivalence evidence. Pearson Clinical. pearsonclinical.ca

3. Randolph, C., Tierney, M. C., Mohr, E., & Chase, T. N. (1998). The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity. Journal of Clinical and Experimental Neuropsychology, 20(3), 310-319. pubmed.ncbi.nlm.nih.gov

4. Gold, J. M., Queern, C., Iannone, V. N., & Buchanan, R. W. (1999). Repeatable Battery for the Assessment of Neuropsychological Status as a screening test in schizophrenia I: Sensitivity, reliability, and validity. American Journal of Psychiatry, 156(12), 1944-1950. pubmed.ncbi.nlm.nih.gov

5. Wilde, M. C. (2006). The validity of the Repeatable Battery of Neuropsychological Status in acute stroke. The Clinical Neuropsychologist, 20(4), 702-715. pubmed.ncbi.nlm.nih.gov

6. McKay, C., Wertheimer, J. C., Fichtenberg, N. L., & Casey, J. E. (2008). The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Clinical utility in a traumatic brain injury sample. The Clinical Neuropsychologist, 22(2), 228-241. pubmed.ncbi.nlm.nih.gov

7. Khan, S. H., Perkins, A. J., Unverzagt, F. W., et al. (2025). Improving Recovery and Outcomes Every Day after the Intensive Care Unit (IMPROVE): A randomized controlled trial. Critical Care Medicine, 53, e1542-e1553. pmc.ncbi.nlm.nih.gov

Hero photo: an empty medical exam room with an examination table and wall-mounted diagnostic instruments. Photo by Harrison Keely via Wikimedia Commons, CC BY 4.0 (https://creativecommons.org/licenses/by/4.0), cropped.